Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Mouse Eph Receptor A2 ELISA Kit (AC3143)
Cat.#: ASET-1732
Specifications
Description Mouse Eph Receptor A2 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of mouse Eph Receptor A2 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Mouse Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 5.27 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 75-1200 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2246 Human NT-4 ELISA Kit (AC3657) Quantitative inquiry ASET-1865 Rat Mu Opioid Receptor ELISA Kit (AC3276) Quantitative inquiry ASET-1919 Human LAMP1 ELISA Kit (AC3330) Quantitative inquiry ASET-1164 Human SATB2 ELISA Kit (AC2575) Quantitative inquiry ASET-2292 Human Semaphorin 3c ELISA Kit (AC3703) Quantitative inquiry ASET-1666 Porcine Ghrelin ELISA Kit (AC3077) Quantitative inquiry ASET-1032 Human TrkC ELISA Kit (AC2443) Quantitative inquiry ASET-1144 Human Neuroglobin ELISA Kit (AC2555) Quantitative inquiry ASET-1444 Human SorCS1 ELISA Kit (AC2855) Quantitative inquiry ASET-1279 Human SLC25A12 ELISA Kit (AC2690) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket